In compliance with the provisions of Regulation 31A(8)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘Listing Regulations’), Pharmaids Pharmaceuticals has informed that on 20th July 2023, the Company has received request from Abhilekha Jain, who is holding 34,128 Equity shares of the Company and who is presently classified as part of Promoter and Promoter Group of the Company, for reclassification as a public shareholder.
The above information is a part of company’s filings submitted to BSE.
